Citigroup »

Mineralys Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $409k 15k 27.09
2025-03-31 $333k 21k 15.88
2024-12-31 $288k 23k 12.31
2024-09-30 $266k 22k 12.09
2024-06-30 $91k 7.8k 11.68
2024-03-31 $51k 4.0k 12.91
2023-12-31 $33k 3.8k 8.60
2023-09-30 $57 6 9.50